Treace medical concepts inc

美股醫療保健

TMCI 投資分析

看多重點:

  • 價值≥4
  • 股利≥2

分析結論

公司發布財報數據季度不足,尚無法提供評分

TMCI 近期報酬表現

-1.75%

Treace medical concepts inc

0.98%

同產業平均

0.02%

S&P500

與 TMCI 同產業的標的表現

  • FNA Paragon 28 inc
    價值 -趨勢 1 分波段 2 分籌碼 2 分股利 1 分
    查看更多

TMCI 公司資訊

Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.

TMCI 股價